Meng Pan

87# Ding Jiaqiao Rd
Nanjing, 210009, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Knockdown of ALDH1A3 reduces breast cancer stem cell marker CD44 via the miR-7-TGFBR2-Smad3-CD44 regulatory axis.

Knockdown of ALDH1A3 reduces breast cancer stem cell marker CD44 via the miR-7-TGFBR2-Smad3-CD44 regulatory axis.

Journal: Experimental and therapeutic medicine

Published: July 28, 2020

The surface dominant antigen MUC1 is required for colorectal cancer stem cell vaccine to exert anti-tumor efficacy.

The surface dominant antigen MUC1 is required for colorectal cancer stem cell vaccine to exert anti-tumor efficacy.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: July 10, 2020

Colorectal cancer stem cell vaccine with high expression of MUC1 serves as a novel prophylactic vaccine for colorectal cancer.

Colorectal cancer stem cell vaccine with high expression of MUC1 serves as a novel prophylactic vaccine for colorectal cancer.

Journal: International immunopharmacology

Published: April 21, 2020

MUC1 plays an essential role in tumor immunity of colorectal cancer stem cell vaccine.

MUC1 plays an essential role in tumor immunity of colorectal cancer stem cell vaccine.

Journal: International immunopharmacology

Published: April 06, 2020

miR-7 Reduces Breast Cancer Stem Cell Metastasis via Inhibiting RELA to Decrease ESAM Expression.

miR-7 Reduces Breast Cancer Stem Cell Metastasis via Inhibiting RELA to Decrease ESAM Expression.

Journal: Molecular therapy oncolytics

Published: April 02, 2020

MiR-7 reduces the BCSC subset by inhibiting XIST to modulate the miR-92b/Slug/ESA axis and inhibit tumor growth.

MiR-7 reduces the BCSC subset by inhibiting XIST to modulate the miR-92b/Slug/ESA axis and inhibit tumor growth.

Journal: Breast cancer research : BCR

Published: November 08, 2019

Decreasing New York esophageal squamous cell carcinoma 1 expression inhibits multiple myeloma growth and osteolytic lesions.

Decreasing New York esophageal squamous cell carcinoma 1 expression inhibits multiple myeloma growth and osteolytic lesions.

Journal: Journal of cellular physiology

Published: April 23, 2019

Inhibition of breast cancer growth via miR-7 suppressing ALDH1A3 activity concomitant with decreasing breast cancer stem cell subpopulation.

Inhibition of breast cancer growth via miR-7 suppressing ALDH1A3 activity concomitant with decreasing breast cancer stem cell subpopulation.

Journal: Journal of cellular physiology

Published: March 25, 2019

The Therapeutic Potential of miR-7 in Cancers.

The Therapeutic Potential of miR-7 in Cancers.

Journal: Mini reviews in medicinal chemistry

Published: February 20, 2019

Induction of multiple myeloma cancer stem cell apoptosis using conjugated anti-ABCG2 antibody with epirubicin-loaded microbubbles.

Induction of multiple myeloma cancer stem cell apoptosis using conjugated anti-ABCG2 antibody with epirubicin-loaded microbubbles.

Journal: Stem cell research & therapy

Published: January 09, 2018

D Rhamnose β-Hederin against human breast cancer by reducing tumor-derived exosomes.

D Rhamnose β-Hederin against human breast cancer by reducing tumor-derived exosomes.

Journal: Oncology letters

Published: October 11, 2017

Effective tumor immunity to melanoma mediated by B16F10 cancer stem cell vaccine.

Effective tumor immunity to melanoma mediated by B16F10 cancer stem cell vaccine.

Journal: International immunopharmacology

Published: August 15, 2017

Showing 1-12 of 21

Last Updated: 09/26/2026